fluorides has been researched along with Carcinoma 256, Walker in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelly, H; Sharpington, C; Stone, MG; Van Den Brenk, HA | 1 |
| Baker, BR; Meyer, RB | 1 |
| Baker, BR; Huang, PC | 1 |
| Baker, BR; Lourens, GJ | 2 |
| Baker, BR; Vermeulen, NM | 1 |
| Ashton, WT; Baker, BR | 3 |
| Baker, BR; Wood, WF | 1 |
10 other study(ies) available for fluorides and Carcinoma 256, Walker
| Article | Year |
|---|---|
Lowering of innate resistance of the lungs to the growth of blood-borne cancer cells in states of topical and systemic stress.
Topics: Adrenalectomy; Aminophylline; Anesthesia; Animals; Carcinoma 256, Walker; Cell Survival; Clone Cells; Cyclic AMP; DNA; Epinephrine; Fluorides; Imidazoles; Immunity; Isoproterenol; Lung; Lung Neoplasms; Neoplastic Cells, Circulating; Pentylenetetrazole; Radiation Effects; Rats; Serotonin; Stress, Physiological; Sympatholytics | 1976 |
Irreversible enzyme inhibitors. CXIX. Active-site-directed irreversible inhibitors of dihydrofolic reductase with tissue specificity derived from 2,4,6-triaminopyrimidine with a terminal sulfonyl fluoride at the 5 position.
Topics: Animals; Binding Sites; Carcinoma 256, Walker; Fluorides; Folic Acid Antagonists; Leukemia L1210; Liver; Mice; Pyrimidines; Rats; Sulfonic Acids | 1968 |
Irreversible enzyme inhibitors. CXX. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-substituted 2,4-diamino-5-phenylpyrimidines with tissue specificity.
Topics: Animals; Binding Sites; Carcinoma 256, Walker; Fluorides; Folic Acid Antagonists; Leukemia L1210; Liver; Mice; Pyrimidines; Rats; Sulfonic Acids | 1968 |
Irreversible enzyme inhibitors. CXXIX. p-(4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. V. Effects of substitution on the benzenesulfonyl f
Topics: Animals; Binding Sites; Carcinoma 256, Walker; Fluorides; Folic Acid Antagonists; Isoenzymes; Leukemia, Experimental; Liver; Mice; Rats; Sulfonic Acids; Triazines | 1968 |
Irreversible enzyme inhibitors. CLXXV. Irreversible inhibition of purified dihydrofolic reductase.
Topics: Animals; Carcinoma 256, Walker; Columbidae; Fluorides; Folic Acid Antagonists; Kidney Neoplasms; Leukemia L1210; Liver; Liver Neoplasms; Mice; Rats; Sulfones | 1970 |
Irreversible enzyme inhibitors. CLXXVI. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine by ether bridging to a terminal sulfonyl fluoride.
Topics: Animals; Carcinoma 256, Walker; Ethers; Fluorides; Folic Acid Antagonists; Kidney Neoplasms; Leukemia L1210; Liver; Liver Neoplasms; Mice; Neoplasms, Experimental; Rats; Splenic Neoplasms; Sulfones; Time Factors; Triazines | 1970 |
Irreversible enzyme inhibitors. CLXXIX. Active-site-directed irreversible enzyme inhibitors of dihydrofolate reductase from 1-(3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with oxyamide bridges to a terminal sulfonyl fluoride.
Topics: Animals; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Culture Techniques; Fluorides; Folic Acid Antagonists; Leukemia L1210; Liver; Mice; Neoplasms, Experimental; Rats; Sulfones; Triazines | 1970 |
Irreversible enzyme inhibitors. 178. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with a terminal sulfonyl fluoride.
Topics: Animals; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Culture Techniques; Fluorides; Folic Acid Antagonists; Intestines; Leukemia L1210; Liver; Mice; Neoplasms, Experimental; Rats; Spleen; Sulfones; Triazines | 1970 |
Irreversible enzyme inhibitors. CXXXIX. p-(4,6-Diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. VI. Further studies on effects of substitution on
Topics: Amides; Animals; Benzene Derivatives; Binding Sites; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Fluorides; Folic Acid Antagonists; Isoenzymes; Leukemia L1210; Liver; Mice; Naphthalenes; Propionates; Rats; Spleen; Sulfonic Acids; Toluene; Triazines | 1969 |
Irreversible enzyme inhibitors. 148. Active-site-directed irreversible inhibitors of guanine deaminase derived from 9-phenylguanine bearing a terminal sulfonyl fluoride.
Topics: Aminohydrolases; Animals; Binding Sites; Biological Assay; Carcinoma 256, Walker; Chemical Phenomena; Chemistry, Physical; Fluorides; In Vitro Techniques; Iodine Isotopes; Liver; Purines; Rabbits; Rats; Sulfones | 1969 |